A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 2

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

July 26, 2024

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Narcolepsy Type 2
Interventions
DRUG

ALKS 2680

Oral tablet containing ALKS 2680

DRUG

Placebo

Oral tablet containing placebo for once daily administration

Trial Locations (47)

2113

Alkermes Investigator Site, Macquarie Park

3570

Alkermes Investigational Site, Alken

5042

Alkermes Investigator Site, Bedford Park

5101

Alkermes Investigational Site, Namur

19001

Alkermes Investigator Site, Abington

19107

Alkermes Investigational Site, Philadelphia

19610

Alkermes Investigator Site, Wyomissing

20132

Alkermes Investigational Site, Milan

28036

Alkermes Investigational Site, Madrid

28037

Alkermes Investigator Site, Denver

28043

Alkermes Investigational Site, Madrid

28078

Alkermes Investigator Site, Huntersville

29201

Alkermes Investigator Site, Columbia

30281

Alkermes Investigator Site, Stockbridge

30328

Alkermes Investigator Site, Atlanta

31210

Alkermes Investigational Site, Macon

32789

Alkermes Investigator Site, Winter Park

33076

Alkermes Investigational Site, Bordeaux

33176

Alkermes Investigator Site, Miami

33511

Alkermes Investigator Site, Brandon

37134

Alkermes Investigational site, Verona

38700

Alkermes Investigational Site, La Tronche

40139

Alkermes Investigational Site, Bologna

44195

Alkermes Investigational Site, Cleveland

44718

Alkermes Investigator Site, Canton

45212

Alkermes Investigator Site, Cincinnati

45245

Alkermes Investigator Site, Cincinnati

48314

Alkermes Investigator Site, Sterling Heights

48911

Alkermes Investigator Site, Lansing

53792

Alkermes Investigational Site, Madison

61637

Alkermes Investigational Site, Peoria

68506

Alkermes Investigator Site, Lincoln

72211

Alkermes Investigator Site, Little Rock

77478

Alkermes Investigational Site, Sugar Land

Alkermes Investigator Site, Sugarland

78229

Alkermes Investigator Site, San Antonio

78731

Alkermes Investigator Site, Austin

80045

Alkermes Investigational Site, Aurora

80918

Alkermes Investigator Site, Colorado Springs

90025

Alkermes Investigator Site, Los Angeles

92705

Alkermes Investigator Site, Santa Ana

94063

Alkermes Investigator Site, Redwood City

94143

Alkermes Investigator Site, San Francisco

07748

Alkermes Investigator Site, Middletown

128 21

Alkermes Investigational Site, Prague

8025BV

Alkermes Investigational Site, Zwolle

08036

Alkermes Investigational Site, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alkermes, Inc.

INDUSTRY